Comparing the EQ-5D 3L and 5L: Measurement properties and association with chronic conditions and multimorbidity in the general population

Health and Quality of Life Outcomes

Volumn 12, Issue 1, 2014, Pages

  Agborsangaya, Calypse B ^a   Lahtinen, Markus ^b   Cooke, Tim ^b   Johnson, Jeffrey A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Health Quality Council of Alberta   (Canada)

Author keywords

Canada; Chronic diseases; EQ 5D; Health related quality of life; Multimorbidity; Quality of life; Shannon index

Indexed keywords

ADULT; ARTICLE; CANADA; CHRONIC DISEASE; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EQ 5D 3L; EQ 5D 5L; FEASIBILITY STUDY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; SCORING SYSTEM; TELEPHONE INTERVIEW;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 84901196534     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-12-74     Document Type: Article

References (22)

1. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33:337-343. 10.3109/07853890109002087, 11491192.
2. Fortin M, Bravo G, Hudon C, Lapointe L, Almirall J, Dubois M-F, Vanasse A. Relationship between multimorbidity and health-related quality of life of patients in primary care. Qual Life Res 2006, 15:83-91. 10.1007/s11136-005-8661-z, 16411033.
3. Agborsangaya CB, Lau D, Lahtinen M, Cooke T, Johnson JA. Health-related quality of life and healthcare utilization in multimorbidity: results of a cross-sectional survey. Qual Life Res 2013, 22:791-799. 10.1007/s11136-012-0214-7, 22684529.
4. Pickard AS, De Leon MC, Kohlmann T, Cella D, Rosenbloom S. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care 2007, 45:259-263. 10.1097/01.mlr.0000254515.63841.81, 17304084.
5. Pickard AS, Kohlmann T, Janssen MF, Bonsel G, Rosenbloom S, Cella D. Evaluating equivalency between response systems: application of the Rasch model to a 3-level and 5-level EQ-5D. Med Care 2007, 45:812-819. 10.1097/MLR.0b013e31805371aa, 17712251.
6. Janssen MF, Birnie E, Haagsma JA, Bonsel GJ. Comparing the standard EQ-5D three-level system with a five-level version. Value Health 2008, 11:275-284. 10.1111/j.1524-4733.2007.00230.x, 18380640.
7. Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P, Busschbach J. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res 2013, 22(7):1717-1727. 10.1007/s11136-012-0322-4, 3764313, 23184421.
8. Scalone L, Ciampichini R, Fagiuoli S, Gardini I, Fusco F, Gaeta L, Del Prete A, Cesana G, Mantovani LG. Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Qual Life Res 2013, 22:1707-1716. 10.1007/s11136-012-0318-0, 23192232.
9. Kim SH, Kim HJ, Lee SI, Jo MW. Comparing the psychometric properties of the EQ-5D 3L and EQ-5D 5L in cancer patients in Korea. Qual Life Res 2012, 21:1065-1073. 10.1007/s11136-011-0018-1, 21947656.
10. HQCA Satisfaction and Experience with Health Care Services: A Survey of Albertans 2010, Calgary: Health Quality Council of Alberta, HQCA.
11. Agborsangaya CB, Lau D, Lahtinen M, Cooke T, Johnson JA. Multimorbidity prevalence and patterns across socioeconomic determinants: a cross-sectional survey. BMC Public Health 2012, 12:201. 10.1186/1471-2458-12-201, 3353224, 22429338.
12. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005, 43:203-220. 10.1097/00005650-200503000-00003, 15725977.
13. van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS. Interim scoring for the EQ-5D 5L: mapping the EQ-5D 5L to EQ-5D 3L value sets. Value Health 2012, 15:708-715. 10.1016/j.jval.2012.02.008, 22867780.
14. Kaplan RM. The minimally clinically important difference in generic utility-based measures. COPD 2005, 2:91-97. 10.1081/COPD-200052090, 17136968.
15. Shannon CE. The mathematical theory of communication. 1963. MD Comput 1997, 14:306-317.
16. Rao GS, Hamid Z, Rao JS. The information content of DNA and evolution. J Theor Biol 1979, 81:803-807. 10.1016/0022-5193(79)90282-0, 537398.
17. Dahl FA, Østerås N. Quantifying information content in survey data by entropy. Entropy 2010, 2:161-163.
18. Janssen MF, Birnie E, Bonsel GJ. Quantification of the level descriptors for the standard EQ-5D three-level system and a five-level version according to two methods. Qual Life Res 2008, 17:463-473. 10.1007/s11136-008-9318-5, 2275305, 18320352.
19. Polinder S, Haagsma JA, Bonsel G, Essink-Bot ML, Toet H, van Beeck EF. The measurement of long-term health-related quality of life after injury: comparison of EQ-5D and the health utilities index. Inj Prev 2010, 16:147-153. 10.1136/ip.2009.022418, 20570982.
20. Lame IE, Peters ML, Vlaeyen JW, Kleef M, Patijn J. Quality of life in chronic pain is more associated with beliefs about pain, than with pain intensity. Eur J Pain 2005, 9:15-24. 10.1016/j.ejpain.2004.02.006, 15629870.
21. Horng YS, Hwang YH, Wu HC, Liang HW, Mhe YJ, Twu FC, Wang JD. Predicting health-related quality of life in patients with low back pain. Spine 2005, 30:551-555. 10.1097/01.brs.0000154623.20778.f0, 15738789.
22. Diederichs C, Berger K, Bartels DB. The measurement of multiple chronic diseases-a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci 2011, 66:301-311.